Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT05225935

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05225935
Other papers using this trial's data
  • Computed tomography-guided vs conventional catheter ablation for ventricular tachycardia: the InEurHeart trial European heart journal, 2026-06-16 DOI, PubMed 41667137, PMC13291909 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, France, Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05225935. Randomized; single masking; primary purpose treatment. Start 2022-06-29 (actual); primary completion 2023-12-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia
Acronym
InEurHeart
Condition
Ventricular Tachycardia
Intervention (Device)
image-guided VT ablation strategy
Intervention (Device)
conventional VT ablation strategy
Lead sponsor
University Hospital, Bordeaux (class: other)
Collaborator
EIT Health (class: other)

Record details

Record id
cardio:ct-nct05225935
Content hash
3ae920c743c719f3412aacfd19d3586c31809c2d1d9ca742cf55c91d8981ce77